Skip to main content

Table 9 Medical costs during the baseline and post-acute phasesa stratified by disposition during acute COVID-19

From: Substantial health and economic burden of COVID-19 during the year after acute illness among US adults not at high risk of severe COVID-19

Cost description

No hospitalization

(n = 3546)

Hospitalization without ICU admission

(n = 164)

ICU admission

(n = 82)

Baseline phase

Post-acute phase

Change from baseline to post-acute phase,

Δ (% change)

Baseline phase

Post-acute phase

Change from baseline to post-acute phase, Δ (% change)

Baseline phase

Post-acute phase

Change from baseline to post-acute phase, Δ (% change)

Inpatient visits

 Total cost

304,291

2,062,445

1,758,153 (577.8)

32,803

486,273

453,469 (1382.4)

0

983,061

983,061 (NC)

 Standard costs, patient n

18

63

 

3

16

 

0

15

 

 Mean ± SD

16,905 ± 9847

32,737 ± 38,912

15,832 (93.7)

10,934 ± 10,516

30,392 ± 28,430

19,458 (177.9)

NC

65,537 ± 65,556

65,537 (NC)

 Median (Q1; Q3)

14,777 (11,159; 20,114)

16,007 (11,786; 44,054)

1229 (8.3)

10,701 (537; 21,566)

27,602 (2506; 49,195)

16,902 (158.0)

NC

40,266 (4928; 120,540)

40,266 (NC)

 Nonzero costs, patient n

18

63

45 (250.0)

3

13

10 (333.3)

0

15

15 (NC)

 Mean ± SD

16,905 ± 9847

32,737 ± 38,912

15,832 (93.7)

10,934 ± 10,516

37,406 ± 26,946

26,471 (242.1)

NC

65,537 ± 65,556

65,537 (NC)

 Median (Q1; Q3)

14,777 (11,159; 20,114)

16,007 (11,786; 44,054)

1229 (8.3)

10,701 (537; 21,566)

38,496 (16,802; 53,778)

27,795 (259.7)

NC

40,266 (4928; 120,540)

40,266 (NC)

Readmission

 Total cost

0

367,979

367,979 (NC)

0

236,797

236,797 (NC)

0

691,151

691,151 (NC)

 Standard costs, patient n

0

7

 

0

7

 

0

9

 

 Mean ± SD

NC

52,568 ± 56,501

52,568 (NC)

NC

33,828 ± 24,414

33,828 (NC)

NC

76,795 ± 58,354

76,795 (NC)

 Median (Q1; Q3)

NC

25,493 (12,064; 125,240)

25,493 (NC)

NC

37,651 (16,802; 53,778)

37,651 (NC)

NC

65,694 (38,770; 118,210)

65,694 (NC)

 Nonzero costs, patient n

0

7

7 (NC)

0

6

6 (NC)

0

9

9 (NC)

 Mean ± SD

NC

52,568 ± 56,501

52,568 (NC)

NC

39,466 ± 21,171

39,466 (NC)

NC

76,795 ± 58,354

76,795 (NC)

 Median (Q1; Q3)

NC

25,493 (12,064; 125,240)

25,493 (NC)

NC

38,766 (17,217; 53,778)

38,766 (NC)

NC

65,694 (38,770; 118,210)

65,694 (NC)

Outpatient visits

 Total cost

4,440,316

10,621,198

6,180,882 (139.2)

186,676

1,180,731

994,056 (532.5)

74,423

455,281

380,857 (511.7)

 Standard costs, patient n

2865

3106

 

113

145

 

48

65

 

 Mean ± SD

1550 ± 2616

3420 ± 8433

1870 (120.6)

1652 ± 2294

8143 ± 29,601

6491 (392.9)

1550 ± 2910

7004 ± 13,389

5454 (351.7)

 Median (Q1; Q3)

667 (280; 1762)

1351 (510; 3300)

684 (102.5)

626 (275; 1962)

1752 (465; 5795)

1126 (180.0)

393 (160; 1229)

1672 (743; 4673)

1279 (325.5)

 Nonzero costs, patient n

2864

3105

241 (8.4)

113

145

32 (28.3)

48

65

17 (35.4)

 Mean ± SD

1550 ± 2617

3421 ± 8434

1870 (120.6)

1652 ± 2294

8143 ± 29,601

6491 (392.9)

1550 ± 2910

7004 ± 13,389

5454 (351.7)

 Median (Q1; Q3)

667 (280; 1764)

1351 (510; 3300)

684 (102.5)

626 (275; 1962)

1752 (465; 5795)

1126 (180.0)

393 (160; 1229)

1672 (743; 4673)

1279 (325.5)

Emergency department visits

 Total cost

708,502

985,099

276,597 (39.0)

48,565

81,825

33,260 (68.5)

20,978

21,880

903 (4.3)

 Standard costs, patient n

356

428

 

27

34

 

9

9

 

 Mean ± SD

1990 ± 1472

2302 ± 2198

311 (15.6)

1799 ± 1419

2407 ± 2466

608 (33.8)

2331 ± 2258

2431 ± 1595

100 (4.3)

 Median (Q1; Q3)

1661 (1064; 2676)

1686 (1080; 2745)

25 (1.5)

1491 (951; 2391)

1581 (724; 3152)

90 (6.1)

1012 (905; 3223)

1991 (1422; 2774)

978 (96.7)

 Nonzero costs, patient n

355

428

73 (20.6)

27

34

7 (25.9)

9

9

0 (0.0)

 Mean ± SD

1996 ± 1470

2302 ± 2198

306 (15.3)

1799 ± 1419

2407 ± 2466

608 (33.8)

2331 ± 2258

2431 ± 1595

100 (4.3)

 Median (Q1; Q3)

1663 (1067; 2684)

1686 (1080; 2745)

22 (1.3)

1491 (951; 2391)

1581 (724; 3152)

90 (6.1)

1012 (905; 3223)

1991 (1422; 2774)

978 (96.7)

Prescription claims

 Total cost

1,169,654

1,417,668

248,013 (21.2)

48,249

141,684

93,435 (193.7)

9112

60,793

51,681 (567.2)

 Standard costs, patient n

2197

2432

 

94

114

 

36

57

 

 Mean ± SD

532 ± 2109

583 ± 2083

51 (9.5)

513 ± 1751

1243 ± 4089

730 (142.1)

253 ± 718

1067 ± 2016

813 (321.4)

 Median (Q1; Q3)

76 (22; 243)

84 (31; 291)

8 (10.1)

46 (16; 171)

131 (35; 628)

84 (181.1)

43 (22.9; 148.5)

139 (55; 760)

95 (219.2)

 Nonzero costs, patient n

2197

2432

235 (10.7)

94

114

20 (21.3)

36

57

21 (58.3)

 Mean ± SD

532 ± 2109

583 ± 2083

51 (9.5)

513 ± 1751

1243 ± 4089

730 (142.1)

253 ± 718

1067 ± 2016

813 (321.4)

 Median (Q1; Q3)

76 (22; 243)

84 (31; 291)

8 (10.1)

46 (16; 171)

131 (35; 628)

84 (181.1)

43 (22.9; 148.5)

139 (55; 760)

95 (219.2)

All medical costs (outpatient, inpatient, and prescription claims)

 Total cost

5,914,262

14,101,310

8,187,048 (138.4)

267,728

1,808,688

1,540,960 (575.6)

83,535

1,499,135

1,415,600 (1694.6)

 Standard costs, patient n

3034

3211

 

128

152

 

53

67

 

 Mean ± SD

1949 ± 3668

4392 ± 11,640

2442 (125.3)

2092 ± 3625

11,899 ± 35,146

9808 (468.9)

1576 ± 2890

22,375 ± 50,108

20,799 (1319.6)

 Median (Q1; Q3)

776 (288; 2068)

1510 (521; 3792)

734 (94.5)

626 (235; 2050)

1990 (439; 7527)

1364 (218.0)

379 (161; 1213)

2264 (940; 9140)

1885 (497.8)

 Nonzero costs, patient n

3033

3211

178 (5.9)

128

152

24 (18.8)

53

67

14 (26.4)

 Mean ± SD

1950 ± 3669

4392 ± 11,640

2442 (125.2)

2092 ± 3625

11,899 ± 35,146

9808 (468.9)

1576 ± 2890

22,375 ± 50,108

20,799 (1319.6)

 Median (Q1; Q3)

776 (289; 2068)

1510 (521; 3792)

734 (94.5)

626 (235; 2050)

1990 (439; 7527)

1364 (218.0)

379 (161; 1213)

2264 (940; 9140)

1885 (497.8)

  1. ICU intensive care unit, NC not calculable, Q1 quartile 1, Q3 quartile 3
  2. Standard cost patient n’s (used to calculate standard mean and median) reflect the number of patients who had any healthcare encounter for the specified outcome (e.g., all patients with ≥ 1 outpatient visit during the specified period). Nonzero cost patient n’s (used to calculate nonzero mean and median) reflect the number of patients who had any costs associated with the specified outcome (e.g., all patients with costs > 0 attributable to outpatient visits)
  3. aAll costs are in US dollars rounded to the nearest dollar. The baseline phase was the 12 months before the index date, and the post-acute phase spanned from 1 to 13 months after the index date